Cystic Fibrosis Pediatric Patients Sinonasal Quality of Life Using Trikafta

Overview

About this study

The purpose of this study is to evaluate the impact of the highly effective CFTR modulator, elexacaftor/tezacaftor/ivacaftor (Trikafta) on sinonasal quality of life and symptoms of CF patients utilizing validated Sinonasal Quality of Life Survey (SN-5).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Rickey Carter, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20548146

Mayo Clinic Footer